Literature DB >> 6609996

Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography.

A Godard, J Naulet, M A Peyrat, H Vie, J F Moreau, J D Bignon, J P Soulillou.   

Abstract

Interleukin 2 (IL-2) has been purified by a protocol using gel filtration high performance liquid chromatography (HPLC) and hydrophobic affinity chromatography with blue-trisacryl M. Peripheral blood lymphocytes or tonsillar lymphocytes were stimulated with phytohemagglutinin (PHA). Serum free conditioned medium (CM) containing IL-2, other lymphokines and residual PHA molecules was analyzed after 3 variations of ammonium sulfate (AS) precipitation: (1) precipitation of CM with 50% AS yielded a precipitate containing most of the residual PHA but also a fraction of IL-2. (2) Precipitation with direct 80% AS of crude CM yielded both IL-2 and residual PHA. (3) A double step procedure (50% AS followed by 80% AS) yielded a precipitate containing IL-2 but free of residual lectin. HPLC purification of these various AS-precipitated materials or of lyophilized crude CM yielded 2 peaks with mitogenic activity as assayed with the CTLL2 murine clone or IL-2-dependent human Con A-stimulated lymphoblasts. IFN was easily separated from IL-2 and PHA, but BCGF still copurified with IL-2. Peak I (25 kDa) was enriched 400-fold for IL-2 while peak II (68 kDa) contained the residual PHA. The IL-2-containing fractions eluted from HPLC were further purified by blue-trisacryl M chromatography. The IL-2 eluted with 0.4 M NaCl. The entire protocol (HPLC followed by blue-trisacryl) led routinely to 8000-fold IL-2 enrichment. Preparative HPLC directly applied to lyophilized crude (CM) enriched IL-2 activity 400-fold with yield averaging 60% of the IL-2 input. The final material was free from interferon and IL-1, but BCGF still copurified with IL-2. The 2-step purified material (HPLC and blue-trisacryl) gave 2 bands in SDS-PAGE both of which contained IL-2.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609996     DOI: 10.1016/0022-1759(84)90188-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis.

Authors:  J F Moreau; M Bonneville; M A Peyrat; A Godard; Y Jacques; C Desgranges; J P Soulillou
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Characterization of human interleukin 2 derived from Escherichia coli.

Authors:  S M Liang; B Allet; K Rose; M Hirschi; C M Liang; D R Thatcher
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

3.  Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis.

Authors:  E Chailleux; J D Bignon; M A Peyrat; A Godard; J P Soulillou
Journal:  Thorax       Date:  1985-10       Impact factor: 9.139

4.  Control of human T-colony formation by interleukin-2.

Authors:  M Jourdan; T Commes; B Klein
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

5.  Cellular immune response in rnu/rnu rats. I. Lectin responsiveness and IL-2 production kinetics of natural cytotoxicity and spleen-cell surface marker expression.

Authors:  A Sfaksi; M Bonneville; J P Soulillou
Journal:  Immunology       Date:  1985-08       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.